WNT7A helps guide early development, especially how the arms, legs, and parts of the reproductive system form before birth. This gene plays an important role in cell to cell signals that tell growing tissues where to develop. Pathogenic variants in the WNT7A gene can cause genetic conditions that affect limb growth, sometimes leading to differences in the hands, feet, pelvis, or lower legs, and in some people changes in reproductive anatomy. WNT7A is mainly known in genetics clinics rather than through public culture or celebrity stories.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or manage processes in the body. Some genes provide the information needed to make proteins, the active parts of cells. Other genes mainly guide when certain processes happen, where they take place, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
WNT7AGene function
What if the gene works
The WNT7A gene helps guide early development of the arms, legs, hands, and feet. It also supports normal development of the female reproductive tract.
Risk
What if the gene does not work
Variants in the WNT7A gene can disrupt early limb formation, causing a spectrum from milder hand or foot differences to marked shortening or absence of some limb bones. The variant often influences which features appear and how severe they are.
Treatment
What does that mean for your treatment
For people with a pathogenic variant in the WNT7A gene, no gene-specific treatment or drug selection approach is currently established. The WNT7A gene is being studied in cancer and developmental research as a pathway marker and possible drug target, but this has not led to routine care.
Conditions associated with WNT7A
Gene function
What if the gene works
During early development, cells need clear signals to grow into the right body parts in the right places. The WNT7A gene helps send some of these signals, especially while limbs and other tissues are taking shape. Its usual job is to guide body planning and support organized growth.
The WNT7A gene makes a signaling protein that lets nearby cells share instructions during development. These messages help cells respond in a coordinated way as tissues form.
One of its best known roles is helping the developing arms and legs form with the correct top and bottom layout. This is central to what the WNT7A gene does in early limb development.
WNT7A signaling helps cells understand position, so growing tissues can form in an organized pattern. This supports normal shaping of structures as the embryo develops.
The protein from the WNT7A gene helps some cells keep the right developmental program as they mature. That guidance helps tissues become more specialized in a controlled way.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the WNT7A gene can change the shape, stability, or release of the WNT7A signaling protein, so cells receive a weaker developmental signal. In plain terms, how WNT7A gene variants affect protein signaling can range from a partial drop in activity to almost complete loss, depending on the change. Milder variants may leave some signaling intact, while more severe variants often disrupt limb development more strongly and can be linked to earlier or broader limb differences.
How variants are linked to conditions
Pathogenic variants in both copies of the WNT7A gene are linked to rare inherited limb conditions. The main WNT7A gene conditions are Fuhrmann syndrome and Al-Awadi-Raas-Rothschild syndrome, also called Schinzel phocomelia syndrome. These diagnoses involve differences in the growth of the arms, legs, hands, or feet before birth, and the exact pattern can vary from person to person.
A variant is not necessarily a diagnosis
Variants in genes are a routine feature of human biology and are widely found across the population. Most do not directly affect health and instead represent normal human variation. For many genes, having a variant associated with a condition suggests a potential link rather than establishing a diagnosis, particularly when several genes and environmental influences play a role. In certain situations, though, one well-characterized variant in a particular gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For WNT7A-related conditions, risk is mostly set by the gene change a child inherits rather than by lifestyle or environmental factors. When both parents carry a disease-causing WNT7A variant, the chance for an affected child is higher with each pregnancy. There is not enough evidence to say that diet, exercise, or other daily habits change this genetic risk.
Inheritance of WNT7A variants
For families asking about the WNT7A inheritance pattern, disease-causing variants in the WNT7A gene are usually inherited in an autosomal recessive way. This means a child inherits one altered copy from each parent. Parents who each carry one variant are often unaffected, but with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with no familial variant. Sons and daughters are affected equally.
What does my WNT7A result mean for my family?
For families with a disease-causing WNT7A result linked to a known WNT7A condition, this usually means close relatives may also be carriers, and brothers or sisters could also be affected. Parents are often healthy carriers, while children usually become carriers unless the other parent also carries a disease-causing WNT7A change. Family testing can help clarify who in the family may be affected or may carry the gene change.
Genetic information
Genetic testing
How you find out about variants
WNT7A genetic testing looks for variants in the WNT7A gene using a blood sample, saliva, or sometimes a cheek swab. A lab reads the gene’s DNA code to check for changes linked to certain limb and reproductive tract conditions. Results may show a pathogenic variant, a benign finding, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the WNT7A gene may be worth considering when a baby or child has unusual limb development, such as missing or very underdeveloped fingers, toes, hands, feet, or lower legs. It can also be helpful when these rare limb differences run in the family, to help confirm the genetic cause.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at the target tissue. This helps explain why the same medicine may work well for one person, work less well for another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how inherited genetic differences shape the way people respond to medications. It looks at gene-drug relationships to help explain why the same treatment can work differently from one person to another. With many medicines, genes affect both how a drug is handled by the body and how strong its effects are. This information can support more informed, personalized treatment choices. More detail on this topic is available in the LearnHub.
Drugs influenced by the WNT7A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used. If you have concerns about side effects, how well a treatment is working, or how it fits with your overall health, talk with your doctor.
History
The WNT7A gene entered medical genetics through research on how limbs form during early development. In the 1990s, as studies of the WNT gene family expanded, scientists linked changes in the WNT7A gene to rare inherited conditions affecting the hands, feet, and lower limbs. Initially understood only through visible traits, later recognized as tied to a specific gene, these conditions helped connect clinical observations with developmental genetics. From these first observations, research expanded steadily. Later work also linked the WNT7A gene to some differences in reproductive development, broadening its place in human genetics. Over time, descriptions became more precise as genetic testing made diagnosis more accurate for affected families.